Download PDF
J Knee Surg 2022; 35(05): 553-559
DOI: 10.1055/s-0040-1716377
Original Article

Low-Dose Aspirin is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Knee Arthroplasty: A Retrospective Cohort Study

Alex Tang 
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Stephen G. Zak
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Daniel Waren
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Richard Iorio
2   Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, Massachusetts
,
James D. Slover
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Joseph A. Bosco
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
,
Ran Schwarzkopf
1   Department of Orthopedic Surgery, NYU Langone Health, New York, New York
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Venous thromboembolism (VTE) events are rare, but serious complications of total joint replacement affect patients and health care systems due to the morbidity, mortality, and associated cost of its complications. There is currently no established universal standard of care for prophylaxis against VTE in patients undergoing revision total knee arthroplasty (rTKA). The aim of this study was to determine whether a protocol of 81-mg aspirin (ASA) bis in die (BID) is safe and/or sufficient in preventing VTE in patients undergoing rTKAs versus 325-mg ASA BID. In 2017, our institution adopted a new protocol for VTE prophylaxis for arthroplasty patients. Patients initially received 325-mg ASA BID for 1 month and then changed to a lower dose of 81-mg BID. A retrospective review from 2011 to 2019 was conducted identifying 1,438 consecutive rTKA patients and 90-day postoperative outcomes including VTE, gastrointestinal, and wound bleeding complications, acute periprosthetic joint infection, and mortality. In the 74 months prior to protocol implementation, 1,003 rTKAs were performed and nine VTE cases were diagnosed (0.90%). After 26 months of the protocol change, 435 rTKAs were performed with one VTE case identified (0.23%). There was no significant difference in rates or odds in postoperative pulmonary embolism (PE; p = 0.27), DVT (p = 0.35), and total VTE rates (p = 0.16) among patients using either protocol. There were also no differences in bleeding complications (p = 0.15) or infection rate (p = 0.36). No mortalities were observed. In the conclusion, 81-mg ASA BID is noninferior to 325-mg ASA BID in maintaining low rates of VTE and may be safe for use in patients undergoing rTKA.

Keywords

deep venous thrombosis - pulmonary embolism - aspirin - venous thromboembolism prophylaxis - revision total knee arthroplasty - bleeding - infection - mortality


Publication History

Received: 30 April 2020

Accepted: 21 July 2020

Article published online:
08 September 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Saleh KJ, Hoeffel DP, Kassim RA, Burstein G. Complications after revision total knee arthroplasty. J Bone Jt Surg Am 2003; 85-A (suppl. 1): S71-S74
    CrossrefPubMedGoogle Scholar
  • 2 Cionac Florescu S, Anastase D-M, Munteanu A-M, Stoica IC, Antonescu D. Venous thromboembolism following major orthopedic surgery. Maedica (Buchar) 2013; 8 (02) 189-194
    PubMedGoogle Scholar
  • 3 Falck-Ytter Y, Francis CW, Johanson NA. et al. Prevention of VTE in orthopedic surgery patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141 (2 suppl.): e278S-e325S
    CrossrefPubMedGoogle Scholar
  • 4 Shahi A, Chen AF, Tan TL, Maltenfort MG, Kucukdurmaz F, Parvizi J. The Incidence and economic burden of in-hospital venous thromboembolism in the United States. J Arthroplasty 2017; 32 (04) 1063-1066
    CrossrefPubMedGoogle Scholar
  • 5 Bozic KJ, Kamath AF, Ong K. et al. Comparative epidemiology of revision arthroplasty: failed THA poses greater clinical and economic burdens than failed TKA. Clin Orthop Relat Res 2015; 473 (06) 2131-2138
    CrossrefPubMedGoogle Scholar
  • 6 Deirmengian GK, Heller S, Smith EB, Maltenfort M, Chen AF, Parvizi J. Aspirin can be used as prophylaxis for prevention of venous thromboembolism after revision hip and knee arthroplasty. J Arthroplasty 2016; 31 (10) 2237-2240
    CrossrefPubMedGoogle Scholar
  • 7 Shahi A, Bradbury TL, Guild III GN, Saleh UH, Ghanem E, Oliashirazi A. What are the incidence and risk factors of in-hospital mortality after venous thromboembolism events in total hip and knee arthroplasty patients?. Arthroplast Today 2018; 4 (03) 343-347
    CrossrefPubMedGoogle Scholar
  • 8 Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 2018; 100 (17) 1455-1460
    CrossrefPubMedGoogle Scholar
  • 9 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Jt Surg Am 2007; 89 (04) 780-785
    CrossrefPubMedGoogle Scholar
  • 10 Pulmonary Embolism Prophylaxis in More Than 30,000 Total Knee Arthroplasty Patients: Is There a Best Choice?. Available at: Accessed October 23, 2019 https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0883540311001641?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0883540311001641%3Fshowall%3Dtrue&referrer = %2F%2Fwww.ncbi.nlm
    PubMed
  • 11 Schousboe JT, Brown GA. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty. J Bone Jt Surg Am 2013; 95 (14) 1256-1264
    CrossrefPubMedGoogle Scholar
  • 12 Azboy I, Barrack R, Thomas AM, Haddad FS, Parvizi J. Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions. Bone Joint J 2017; 99-B (11) 1420-1430
    CrossrefPubMedGoogle Scholar
  • 13 Parvizi J, Ceylan HH, Kucukdurmaz F, Merli G, Tuncay I, Beverland D. Venous thromboembolism following hip and knee arthroplasty. J Bone Joint Surg Am 2017; 99 (11) 961-972
    CrossrefPubMedGoogle Scholar
  • 14 Collaborative overview of randomised trials of antiplatelet therapy--III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ 1994; 308 (6923): 235-246
    CrossrefPubMedGoogle Scholar
  • 15 Lieberman JR, Heckmann N. Venous thromboembolism prophylaxis in total hip arthroplasty and total knee arthroplasty patients: from guidelines to practice. J Am Acad Orthop Surg 2017; 25 (12) 789-798
    CrossrefPubMedGoogle Scholar
  • 16 Sharrock NE, Gonzalez Della Valle A, Go G, Lyman S, Salvati EA. Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res 2008; 466 (03) 714-721
    CrossrefPubMedGoogle Scholar
  • 17 Huang RC, Parvizi J, Hozack WJ, Chen AF, Austin MS. Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty. J Arthroplasty 2016; 31 (09) 83-86
    CrossrefPubMedGoogle Scholar
  • 18 Budhiparama NC, Abdel MP, Ifran NN, Parratte S. Venous thromboembolism (VTE) prophylaxis for hip and knee arthroplasty: changing trends. Curr Rev Musculoskelet Med 2014; 7 (02) 108-116
    CrossrefPubMedGoogle Scholar
  • 19 Johanson NA, Lachiewicz PF, Lieberman JR. et al. American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am 2009; 91 (07) 1756-1757
    CrossrefPubMedGoogle Scholar
  • 20 Parvizi J, Huang R, Restrepo C. et al. Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty a preliminary analysis. J Bone Joint Surg Am 2017; 99 (02) 91-98
    CrossrefPubMedGoogle Scholar
  • 21 Huang R, Buckley PS, Scott B, Parvizi J, Purtill JJ. Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection. J Arthroplasty 2015; 30 (09) 39-41
    CrossrefPubMedGoogle Scholar
  • 22 Faour M, Piuzzi NS, Brigati DP. et al. Low-dose aspirin is safe and effective for venous thromboembolism prophylaxis following total knee arthroplasty. J Arthroplasty 2018; 33 (7S) S131-S135
    CrossrefPubMedGoogle Scholar
  • 23 Brighton TA, Eikelboom JW, Mann K. et al; ASPIRE Investigators. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012; 367 (21) 1979-1987
    CrossrefPubMedGoogle Scholar
  • 24 Taylor DW, Barnett HJM, Haynes RB. et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet 1999; 353 (9171): 2179-2184
    CrossrefPubMedGoogle Scholar
  • 25 Hernandez AJ, Almeida AM, Fávaro E, Sguizzato GT. The influence of tourniquet use and operative time on the incidence of deep vein thrombosis in total knee arthroplasty. Clinics (São Paulo) 2012; 67 (09) 1053-1057
    CrossrefPubMedGoogle Scholar
  • 26 Gesell MW, González Della Valle A, Bartolomé García S. et al. Safety and efficacy of multimodal thromboprophylaxis following total knee arthroplasty: a comparative study of preferential aspirin vs. routine coumadin chemoprophylaxis. J Arthroplasty 2013; 28 (04) 575-579
    CrossrefPubMedGoogle Scholar
  • 27 Borgdorff P, Tangelder GJ. Arguments favoring low versus high dose aspirin in the prophylaxis of venous thromboembolism. Thromb Res 2016; 139: 121-124
    CrossrefPubMedGoogle Scholar
  • 28 Tohgi H, Konno S, Tamura K, Kimura B, Kawano K. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke 1992; 23 (10) 1400-1403
    CrossrefPubMedGoogle Scholar
  • 29 Feldstein MJ, Low SL, Chen AF, Woodward LA, Hozack WJ. A Comparison of Two Dosing Regimens of ASA Following Total Hip and Knee Arthroplasties. J Arthroplasty 2017; 32 (9S): S157-S161
    CrossrefPubMedGoogle Scholar
  • 30 Valkhoff VE, Sturkenboom MCJM, Hill C, Veldhuyzen van Zanten S, Kuipers EJ. Low-dose acetylsalicylic acid use and the risk of upper gastrointestinal bleeding: a meta-analysis of randomized clinical trials and observational studies. Can J Gastroenterol 2013; 27 (03) 159-167
    CrossrefPubMedGoogle Scholar
  • 31 Cai DF, Fan QH, Zhong HH, Peng S, Song H. The effects of tourniquet use on blood loss in primary total knee arthroplasty for patients with osteoarthritis: a meta-analysis. J Orthop Surg Res 2019; 14 (01) 348
    CrossrefPubMedGoogle Scholar